34905-07-2

Basic information

• Product Name: 1-(Allyloxy)-4-(hydroxymethyl)benzene
• Synonyms: 1-(Allyloxy)-4-(hydroxymethyl)benzene;1-Allyloxy-4-(hydroxymethyl)benzene;4-(Allyloxy)benzenemethanol;4-(Allyloxy)benzyl alcohol;4-Allyloxybenzenemethanol;[3-(allyloxy)phenyl]methanol(SALTDATA: FREE)
• CAS NO: 34905-07-2
• Molecular Formula: C₁₀H₁₂O₂
• Molecular Weight: 164.2
• Mol File: 34905-07-2.mol

Chemical Properties

• Boiling Point: 287.9°C at 760 mmHg
• Flash Point: 127.1°C
• Appearance: /
• Density: 1.056g/cm³
• Vapor Pressure: 0.00112mmHg at 25°C
• Refractive Index: 1.535
• CAS DataBase Reference: 1-(Allyloxy)-4-(hydroxymethyl)benzene(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(Allyloxy)-4-(hydroxymethyl)benzene(34905-07-2)
• EPA Substance Registry System: 1-(Allyloxy)-4-(hydroxymethyl)benzene(34905-07-2)

Safety Data

• Hazardous Substances Data: 34905-07-2(Hazardous Substances Data)

Usage

Uses

Used in Fragrance Industry:
1-(Allyloxy)-4-(hydroxymethyl)benzene is used as a fragrance ingredient for its pleasant scent, contributing to the creation of various cosmetics and personal care products.
Used in Flavor Industry:
This chemical compound serves as a flavoring agent, enhancing the taste of food products and making them more appealing to consumers.
Used in Chemical Synthesis:
1-(Allyloxy)-4-(hydroxymethyl)benzene is utilized in the synthesis of other organic compounds, playing a crucial role in the production of a range of chemical products.
Used in Pharmaceutical Industry:
Due to its chemical properties, 1-(Allyloxy)-4-(hydroxymethyl)benzene has potential applications in the development of pharmaceuticals, although specific uses would require further research and development.
Used in Polymer Production:
1-(Allyloxy)-4-(hydroxymethyl)benzene also acts as a precursor in the production of polymers, which are essential in various industries, including plastics, coatings, and textiles.
It is important to handle 1-(Allyloxy)-4-(hydroxymethyl)benzene with care, as it can be harmful if ingested or inhaled, and it may cause skin and eye irritation.

InChI:InChI=1/C10H12O2/c1-2-6-12-10-5-3-4-9(7-10)8-11/h2-5,7,11H,1,6,8H2

Upstream product

• 100-83-4 meta-hydroxybenzaldehyde 
• 40359-32-8 3-allyloxy-benzaldehyde 

Downstream Products

• 878023-51-9 3-(3-allyloxybenzyloxy)-2-benzyl-3-phenyl-2,3-dihydroisoindol-1-one 
• 271581-03-4 3-hydroxy-4-(2-propenyl)benzyl alcohol 
• 40359-32-8 3-allyloxy-benzaldehyde 

Relevant articles and documents

Turn on chemiluminescence-based probes for monitoring tyrosinase activity in conjunction with biological thiols

We report a chemiluminescent probe (CLPT1) that permits the paired detection of tyrosinase (Tyr) and biological thiols. Tyr only leads to a poor chemiluminescence response, a finding ascribed to the formation of a stableo-benzoquinone intermediate. The addition of glutathione (GSH), or ascorbate to theo-benzoquinone intermediate results in thiol conjugation or reduction to this intermediate, respectively. This produces a strong chemiluminescence response. Thiol co-dependence was demonstrated in live cells using the cell permeable analogue,CLPT3. The present chemiluminescence-based strategy allows the concurrent detection of tyrosinase activity and biological thiols.

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

The disclosure generally relates to compounds of formula I, including compositions and methods for treating human immunodeficiency virus (HIV) infection. The disclosure provides novel inhibitors of HIV, pharmaceutical compositions containing such compounds, and methods for using these compounds in the treatment of HIV infection. Formule (I)

Development of a novel hapten for radioimmunoassay of the lignan, enterolactone in plasma (Serum). Total synthesis of (±)-trans-5- carboxymethoxyenterolactone and several analogues

A recently developed method for the analysis of the mammalian lignan, enterolactone 1, is based on time-resolved fluoroimmunoassay (TR-FIA) using an europium chelate as a label. This RIA utilizes enterolactone derivatives carrying a carboxylic acid appendage for the production of antiserum and tracer. The synthesis of 5-carboxymethoxyenterolactone 6 and analogues 5, 7 and 8 is described, and their suitability for the method are discussed. (C) 2000 Elsevier Science Ltd.

ORTHO SUBSTITUTED AROMATIC COMPOUNDS USEFUL AS ANTAGONISTS OF THE PAIN ENHANCING EFFECTS OF E-TYPE PROSTAGLANDINS

The invention relates to compounds of the formula (I): STR1 wherein A, B and D are various ring systems such as phenyl, R. sup.1 includes carboxy, R 3 is hydrogen or C 1-4 alkyl and Z is a linking group such as--(CH(R 5)) m--wherein m is 2, 3 or 4, and R 5 includes hydrogen and methyl; and pharmaceutically acceptable salts and in vivo hydrolysable esters or amides thereof, processes for preparing these compounds, pharmaceutical compositions comprising them, and their use in the treatment of pain.